期刊文献+

RNAi沉默CD147基因对卵巢癌细胞HO-8910pm生物学行为的影响 被引量:6

Silencing of CD147 by RNAi influences biological behavior of ovarian cancer cell line HO-8910pm.
在线阅读 下载PDF
导出
摘要 目的:采用RNA干扰(RNA interference,RNA i)技术,利用构建的稳定转染CD147 shRNA表达质粒载体的HO-8910pm/pGE-1 CD147shRNA细胞株观察卵巢癌细胞系HO-8910pm CD147基因的沉默作用及生物学效应。方法:用免疫细胞化学法、激光共聚焦检测HO-8910pm细胞CD147的表达;MTT法绘制细胞生长曲线,观察裸鼠卵巢癌皮下移植瘤的成瘤性。结果:pGE-1CD147shRNA转染人卵巢癌细胞系后,CD147的表达受到高效且特异的抑制,细胞侵袭力减弱,荷瘤裸鼠成瘤力下降,抑瘤率达58.8%(P<0.01)。结论:RNA i沉默CD147基因可影响卵巢癌的侵袭和成瘤,有可能成为治疗卵巢癌的新途径。 Objective:To study the effect of CD147 gene silence by RNAi in ovarian cancer cell line HO-8910pm on biological behavior. Methods: Immunohistochemical technique and confocal laser scanning microscope (CLSM) were carried out to assess the expression of CD147 in HO-8910pm cell line. MTT assay was used to observe the effect on proliferation ability;in vitro invasion assay was performed to assess changes of tumor invasion ability. Cells were transplanted subcutaneously in nude mice to observe the tumorigenesis. Results: In HO- 8910pm/pGE-1 CD147shRNA cell ,the expression of CD147 was inhibited specifically and efficiently;no statistical difference of their proliferation abilities was observed but their invasion abilities and tumorigenesis in nude mice decreased significantly. Tumorigenicity inhibition rate reached 58.8% ( P 〈0.01 ) in experimental group. Conclusion: Silencing of CD147 by RNAi can inhibit invasion and tumorigenesis of ovarian cancer and may become a new approach of ovarian cancer therapy.
出处 《现代妇产科进展》 CSCD 北大核心 2006年第2期92-95,F0003,共5页 Progress in Obstetrics and Gynecology
关键词 卵巢肿瘤 RNA干扰 SHRNA 抗原CD147 Ovarian neoplasms RNA interference shRNA Antigens, CD147
  • 相关文献

参考文献12

  • 1Muramatsu T,Miyauchi T.Basigin (CD147):a multifunctional transmembrane protein involved in reproduction,neural function,inflammation and tumor invasion[J].Histol Histopathol,2003,18(3):981-987
  • 2Davidson B,Goldberg I,Berner A,et al.EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma[J].Clin Exp Metastasis,2003,20(2):161-169
  • 3邹伟,辛晓燕,杨红,侯向华.CD147 shRNA真核表达质粒的构建及鉴定[J].肿瘤,2005,25(1):46-50. 被引量:1
  • 4Nabelshima K,Komada N,Kishii J.TPA-enhanced invasion of Matrigel associated with augmentation of cell motility but not metalloproteinase activity in a highly metastatic variant(L-10) of human rectal adenocarcinoma cell line RCM-1[J].Int J Cancer,1993,55:947-981
  • 5Matzke M,Matzke AJ,Kootex JM.RNA:guiding gene silencing[J].Science,2001,293:1080-1083
  • 6Sui G,Soohoo C,Affarel B,et al.A DNA vector-based RNAi technology to suppress gene expression in mammalian cells[J].Proc Natl Acad Sci USA,2002,99:5515-5520
  • 7Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in culture mammalian cells[J].Nature,2001,411:494-498
  • 8Pebernard S,Iggo RD.Determinants of interferon-stimulated gene induction by RNAi vectors[J].Differentiation,2004,72:103-111
  • 9Elbashir SM,Harborth J,Lendeckel W,et al.Duplexes of 21-nucleotide RNAs mediate RNA interference in culture mammalian cells[J].Nature,2001,411:494-498
  • 10Sun J,Hemler ME.Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions[J].Cancer Res,2001,61 (3):2276-2281

二级参考文献34

  • 1[1]Folkman J.What is the evidence that tumors are angiogenesis-dependent[J]? J Natl Cancer,1997,8(2):4-6.
  • 2[2]Maier JA,Delia D,Thorpe PE,et al.In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the anti-endoglin antibody TEC-11[J].Anticancer Drugs,1997,8(3):238-244.
  • 3[3]Rodriguez Nieto S,Medina MA,Quesada AR.A re-evaluation of fumagillin selectivity towards endothelial cells[J].Anticancer Res,2001,21(5):3457-3560.
  • 4[4]Saito N,Mitsuhashi M,Hayashi T,et al.Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470[J].Int J Clin Oncol,2001,6(5):215-220.
  • 5[5]Potgens AJ,Westphal HR,de Waal RM,et al.The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis[J].Biol Chem Hoppe Seyler,1995,376(2):57-70.
  • 6[6]Claffey KP,Brown LF,del Aguila LF,et al.Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth,angiogenesis,and experimental metastasis[J].Cancer Res,1996,56(1):172-181.
  • 7[7]Chow NH,Hsu PI,Lin XZ,et al.Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma:an immunohistochemical study[J].Hum Pathol,1997,28(6):698-703.
  • 8[8]Haddad R,Lipson KE,Webb CP.Hepatocyte growth factor expression in human cancer and therapy with specific inhibitors[J].Anticancer Res,2001,21(6B):4243-4252.
  • 9[9]Iwasaki T,Hamano T,Ogata A,et al.Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma[J].Br J Haematol,2002,116(4):796-802.
  • 10[10]Vinals F,Pouyssegur J.Transforming growth factor beta1 (TGF-beta1) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling[J].Mol Cell Biol,2001,21(21):7218-7230.

共引文献3

同被引文献83

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部